(ANVS) Annovis Bio - Performance -77.7% in 12m
Compare ANVS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-53.00%
#73 in Group
Rel. Strength
5.38%
#7529 in Universe
Total Return 12m
-77.66%
#143 in Group
Total Return 5y
-58.08%
#64 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: ANVS (-77.7%) vs XBI (-14.9%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
7.21% | 14% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
7.98% | 32.4% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-7.04% | -11.2% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
11.7% | 13.3% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
2.2% | 21% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
13.3% | 27.1% | -5.64% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
27.3% | -15% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20% | 0.38% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ANVS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ANVS
| Total Return (including Dividends) | ANVS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 17.69% | 2.77% | 5.69% |
| 3 Months | -39.29% | -14.21% | -6.49% |
| 12 Months | -77.66% | -14.88% | 9.72% |
| 5 Years | -58.08% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | ANVS | XBI | S&P 500 |
| 1 Month | 71.4% | 57% | 89.4% |
| 3 Months | -77.0% | -82.3% | -72% |
| 12 Months | -77.6% | -53.1% | 49.3% |
| 5 Years | -29.7% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #114 | 14.5% | 11.4% |
| 3 Month | #190 | -29.2% | -35.1% |
| 12 Month | #143 | -73.8% | -79.6% |
| 5 Years | #66 | -43.0% | -79.8% |
FAQs
Does ANVS Annovis Bio outperforms the market?
No,
over the last 12 months ANVS made -77.66%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.88%.
Over the last 3 months ANVS made -39.29%, while XBI made -14.21%.
Over the last 3 months ANVS made -39.29%, while XBI made -14.21%.
Performance Comparison ANVS vs Indeces and Sectors
ANVS vs. Indices ANVS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.44% | 12.0% | -74.9% | -87.4% |
| US NASDAQ 100 | QQQ | -1.71% | 10.3% | -75.3% | -88.5% |
| US Dow Jones Industrial 30 | DIA | -1.33% | 15.0% | -73.8% | -83.9% |
| German DAX 40 | DAX | -1.89% | 2.63% | -100% | -102% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.67% | 14.8% | -74.1% | -84.0% |
| Hongkong Hang Seng | HSI | -4.32% | 2.79% | -84.3% | -85.9% |
| India NIFTY 50 | INDA | 2.26% | 14.5% | -76.8% | -79.7% |
| Brasil Bovespa | EWZ | -4.47% | 6.07% | -84.1% | -71.4% |
ANVS vs. Sectors ANVS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.81% | 11.2% | -81.0% | -98.0% |
| Consumer Discretionary | XLY | -2.86% | 11.0% | -72.7% | -92.5% |
| Consumer Staples | XLP | -0.58% | 17.0% | -81.8% | -84.9% |
| Energy | XLE | -3.69% | 13.2% | -68.9% | -68.6% |
| Financial | XLF | -2.14% | 10.9% | -80.7% | -99.2% |
| Health Care | XLV | 2.66% | 20.8% | -69.6% | -71.7% |
| Industrial | XLI | -2.37% | 9.38% | -75.8% | -88.0% |
| Materials | XLB | -1.60% | 12.7% | -70.8% | -71.6% |
| Real Estate | XLRE | -0.65% | 10.8% | -77.2% | -91.2% |
| Technology | XLK | -2.28% | 7.98% | -72.6% | -83.8% |
| Utilities | XLU | -2.16% | 12.6% | -82.6% | -93.7% |
| Aerospace & Defense | XAR | -1.62% | 8.52% | -84.2% | -104% |
| Biotech | XBI | 6.28% | 14.9% | -53.8% | -62.8% |
| Homebuilder | XHB | -1.08% | 12.1% | -61.2% | -68.8% |
| Retail | XRT | -1.50% | 11.6% | -68.6% | -71.4% |